<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04822649</url>
  </required_header>
  <id_info>
    <org_study_id>2020AN0030</org_study_id>
    <nct_id>NCT04822649</nct_id>
  </id_info>
  <brief_title>Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition</brief_title>
  <official_title>Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients With Suspected Heart Failure With Preserved Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Anam Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The correlation of coronary microvascular function and body composition with cardiopulmonary&#xD;
      exercise capacity will be assessed in patients with heart failure with preserved ejection&#xD;
      fraction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will select the patients with chest pain or ischemic symptoms with non-obstructive&#xD;
      coronary artery disease (&lt;50% stenosis) in coronary angiography and preserved ejection&#xD;
      fraction (≥50%) in echocardiography. All patients will undergo body composition analysis and&#xD;
      adenosine stress echocardiography with the evaluation of coronary artery blood flow by&#xD;
      Doppler echocardiography and maximal oxygen consumption (VO2 max) by cardiopulmonary exercise&#xD;
      test. Left ventricular end-diastolic pressure will be assessed during coronary angiography.&#xD;
      Coronary flow reserve (CFR) is defined as the ratio of peak to baseline mean diastolic&#xD;
      velocity of coronary blood flow. The correlation of CFR and body composition with&#xD;
      cardiopulmonary exercise capacity will be assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients with chest pain or ischemic symptoms with non-obstructive coronary artery disease (&lt;50% stenosis) in coronary angiography and preserved ejection fraction (&gt;50%) in echocardiography.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of coronary blood flow with cardiopulmonary exercise capacity</measure>
    <time_frame>up to day 14</time_frame>
    <description>Coronary blood flow is assessed by coronary flow reserve (CFR), which is defined as peak to baseline mean diastolic velocity of coronary flow.&#xD;
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of body composition with cardiopulmonary exercise capacity</measure>
    <time_frame>up to day 14</time_frame>
    <description>In body composition analysis, skeletal muscle mass and body fat mass will be assessed.&#xD;
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure With Preserved Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>Heart failure with preserved ejection fraction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adenosine stress echocardiography, body composition, and cardiopulmonary exercise test will be done in all of the enrolled patients. Left ventricular end-diastolic pressure will be assessed during coronary angiography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Adenosine stress echocardiography with the evaluation of coronary artery blood flow</intervention_name>
    <description>The color Doppler flow of distal left anterior descending artery will be examined from the modified apical four-chamber view in the anterior interventricular groove.&#xD;
In regard to body composition analysis, Using InBody S10, impedance is measured in 6 frequency bands (1kHz, 5kHz, 50kHz, 250kHz, 500kHz, 1000kHz) for each of 5 parts (right plate, left arm, torso, right leg, left leg). Reactance is measured in 3 frequency bands (5kHz, 50kHz, 250kHz for each of 5 parts (right arm, left arm, torso, right leg, left leg).&#xD;
By treadmill exercise test with modified Bruce protocol or bicycle ergometer for patients with orthopedic problems, maximal oxygen consumption (VO2 max) will be measured using the exhalation gas analysis.</description>
    <arm_group_label>Heart failure with preserved ejection fraction</arm_group_label>
    <other_name>Body composition analysis</other_name>
    <other_name>Cardiopulmonary exercise test</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 20 to 80&#xD;
&#xD;
          -  Typical/atypical chest pain or ischemic symptoms including dyspnea&#xD;
&#xD;
          -  No significant coronary artery stenosis (&gt;50% stenosis) in coronary angiography or&#xD;
             computed tomography&#xD;
&#xD;
          -  Left ventricular ejection fraction ≥50%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  More than moderate valvular heart disease&#xD;
&#xD;
          -  Congenital heart disease&#xD;
&#xD;
          -  Chronic renal failure (estimated glomerular filtration rate &lt;30 ml/min/1.73m2) or&#xD;
             end-stage renal failure undergoing hemodialysis or peritoneal dialysis&#xD;
&#xD;
          -  Asthma, chronic obstructive pulmonary disease and primary pulmonary hypertension&#xD;
&#xD;
          -  Receiving anticancer drugs&#xD;
&#xD;
          -  Vasculitis associated with autoimmune diseases&#xD;
&#xD;
          -  Patients with difficulty in performing exercise load evaluation (treadmill, bicycle&#xD;
             ergometer)&#xD;
&#xD;
          -  Atrial fibrillation&#xD;
&#xD;
          -  Atrioventricular block with more than second degrees, symptomatic bradycardia,&#xD;
             cryo-node failure syndrome, Wolff-Parkinson-White (WPW) patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>So Ree Kim, MD</last_name>
    <phone>821094534810</phone>
    <email>soree8826kim@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>So Ree Kim, MD</last_name>
      <email>soree8826kim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Seong-Mi Park</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mi-Na Kim</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>So Ree Kim</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Anam Hospital</investigator_affiliation>
    <investigator_full_name>Seong-Mi Park, M.D. Ph.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Body composition, CPET, CFR, CMD, Frailty, HFpEF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

